BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14704855)

  • 1. Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens.
    Coradini D; Pellizzaro C; Speranza A; Daidone MG
    Cell Mol Life Sci; 2004 Jan; 61(1):76-82. PubMed ID: 14704855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
    Rydén L; Jirström K; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Thorstenson S; Jönsson PE; Landberg G
    J Clin Oncol; 2005 Jul; 23(21):4695-704. PubMed ID: 16034044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ; Zhu BT
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
    Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
    Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism.
    Buteau-Lozano H; Velasco G; Cristofari M; Balaguer P; Perrot-Applanat M
    J Endocrinol; 2008 Feb; 196(2):399-412. PubMed ID: 18252963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells.
    Lee JE; Chung KW; Han W; Kim SW; Kim SW; Shin HJ; Bae JY; Noh DY
    Anticancer Res; 2004; 24(6):3961-4. PubMed ID: 15736439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a human breast cancer cell line, MCF-7/RU58R-1, resistant to the pure antiestrogen RU 58,668.
    Fog CK; Christensen IJ; Lykkesfeldt AE
    Breast Cancer Res Treat; 2005 May; 91(2):133-44. PubMed ID: 15868441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
    Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
    Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
    Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of estrogen receptor in the regulation of estrogen induced amino acid transport of System A in breast cancer and other receptor positive tumor cells.
    Bhat HK; Vadgama JV
    Int J Mol Med; 2002 Mar; 9(3):271-9. PubMed ID: 11836633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts.
    Hartman J; Lindberg K; Morani A; Inzunza J; Ström A; Gustafsson JA
    Cancer Res; 2006 Dec; 66(23):11207-13. PubMed ID: 17145865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation of estrogen induced telomerase activity in tamoxifen-resistant breast cancer cells.
    Park WC; Liu H; Macgregor Schafer J; Jordan VC
    Int J Oncol; 2005 Nov; 27(5):1459-66. PubMed ID: 16211243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
    Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
    Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.
    Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML
    Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.
    Mc Ilroy M; Fleming FJ; Buggy Y; Hill AD; Young LS
    Endocr Relat Cancer; 2006 Dec; 13(4):1135-45. PubMed ID: 17158759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells.
    Fotovati A; Fujii T; Yamaguchi M; Kage M; Shirouzu K; Oie S; Basaki Y; Ono M; Yamana H; Kuwano M
    Clin Cancer Res; 2006 May; 12(10):3010-8. PubMed ID: 16707596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.
    Bianco NR; Perry G; Smith MA; Templeton DJ; Montano MM
    Mol Endocrinol; 2003 Jul; 17(7):1344-55. PubMed ID: 12714703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer.
    Sutherland TE; Schuliga M; Harris T; Eckhardt BL; Anderson RL; Quan L; Stewart AG
    Clin Cancer Res; 2005 Mar; 11(5):1722-32. PubMed ID: 15755993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.